KMB

Key Points to Know About KMB Stock for Investors

Kimberly-Clark shares fell by -1.8% during the day's afternoon session, and are now trading at a price of $118.7. Is it time to buy the dip? To better answer that question, it's essential to check if the market is valuing the company's shares fairly in terms of its earnings and equity levels.

Kimberly-Clark's Valuation Is in Line With Its Sector Averages:

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. The company belongs to the Consumer Discretionary sector, which has an average price to earnings (P/E) ratio of 22.33 and an average price to book (P/B) ratio of 3.12. In contrast, Kimberly-Clark has a trailing 12 month P/E ratio of 24.5 and a P/B ratio of 80.31.

Kimberly-Clark's PEG ratio is 1.93, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

Shareholders Are Confronted With a Declining EPS Growth Trend:

2018-02-08 2019-02-07 2020-02-13 2021-02-11 2022-02-10 2023-02-09
Revenue (MM) $18,348 $18,486 $18,450 $19,140 $19,440 $20,175
Gross Margins 36.0% 30.0% 33.0% 36.0% 31.0% 31.0%
Operating Margins 18% 12% 15% 17% 13% 13%
Net Margins 12.0% 8.0% 12.0% 12.0% 9.0% 10.0%
Net Income (MM) $2,278 $1,410 $2,157 $2,352 $1,814 $1,934
Net Interest Expense (MM) -$308 -$253 -$250 -$244 -$250 -$268
Depreciation & Amort. (MM) -$724 -$882 -$917 -$796 -$766 -$754
Earnings Per Share $6.4 $4.03 $6.24 $6.87 $5.36 $5.65
EPS Growth n/a -37.03% 54.84% 10.1% -21.98% 5.41%
Diluted Shares (MM) 356 350 346 342 338 342
Free Cash Flow (MM) $3,714 $3,796 $2,494 $3,698 $2,687 $2,721
Capital Expenditures (MM) -$785 -$826 $242 $31 $43 $12
Net Current Assets (MM) -$9,058 -$9,523 -$10,032 -$11,480 -$11,509 -$11,283
Long Term Debt (MM) $6,472 $6,247 $6,213 $7,878 $8,141 $7,578
Net Debt / EBITDA 1.67 2.22 1.98 2.02 2.48 2.36

Kimberly-Clark has weak revenue growth and a flat capital expenditure trend, irregular cash flows, and significant leverage. We also note that the company benefits from strong margins with a negative growth trend and wider gross margins than its peer group. However, the firm has declining EPS growth.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS